Prolactin-releasing peptide (PrRP) belongs to the large RF-amide neuropeptide family with a conserved Arg-Phe-amide motif at the C-terminus. PrRP plays a main role in the regulation of food intake and energy expenditure. This review focuses not only on the physiological functions of PrRP, but also on its pharmacological properties and the actions of its G-protein coupled receptor, GPR10. Special attention is paid to structure-activity relationship studies on PrRP and its analogs as well as to their effect on different physiological functions, mainly their anorexigenic and neuroprotective features and the regulation of the cardiovascular system, pain, and stress. Additionally, the therapeutic potential of this peptide and its analogs is explored.

Biochemistry and Molecular Biology Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences 16610 Prague Czech Republic

Experimental Hypertension Institute of Physiology of the Czech Academy of Sciences 14200 Prague Czech Republic

Zobrazit více v PubMed

Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoya M., Fukusumi S., Kitada C., Masuo Y., Asano T., Matsumoto H., et al. A prolactin-releasing peptide in the brain. Nature. 1998;393:272–276. doi: 10.1038/30515. PubMed DOI

Welch S.K., O’Hara B.F., Kilduff T.S., Heller H.C. Sequence and tissue distribution of a candidate G-coupled receptor cloned from rat hypothalamus. Biochem. Biophys. Res. Commun. 1995;209:606–613. doi: 10.1006/bbrc.1995.1543. PubMed DOI

Dodd G.T., Luckman S.M. Physiological Roles of GPR10 and PrRP Signaling. Front. Endocrinol. 2013;4:20–28. doi: 10.3389/fendo.2013.00020. PubMed DOI PMC

Wang Y., Wang C.Y., Wu Y., Huang G., Li J., Leung F.C. Identification of the receptors for prolactin-releasing peptide (PrRP) and Carassius RFamide peptide (C-RFa) in chickens. Endocrinology. 2012;153:1861–1874. doi: 10.1210/en.2011-1719. PubMed DOI

Yamada M., Ozawa A., Ishii S., Shibusawa N., Hashida T., Ishizuka T., Hosoya T., Monden T., Satoh T., Mori M. Isolation and characterization of the rat prolactin-releasing peptide gene: Multiple TATA boxes in the promoter region. Biochem. Biophys. Res. Commun. 2001;281:53–56. doi: 10.1006/bbrc.2001.4308. PubMed DOI

Southey B.R., Rodriguez-Zas S.L., Sweedler J.V. Prediction of neuropeptide prohormone cleavages with application to RFamides. Peptides. 2006;27:1087–1098. doi: 10.1016/j.peptides.2005.07.026. PubMed DOI

Fujimoto M., Takeshita K., Wang X., Takabatake I., Fujisawa Y., Teranishi H., Ohtani M., Muneoka Y., Ohta S. Isolation and characterization of a novel bioactive peptide, Carassius RFamide (C-RFa), from the brain of the Japanese crucian carp. Biochem. Biophys. Res. Commun. 1998;242:436–440. doi: 10.1006/bbrc.1997.7973. PubMed DOI

Sakamoto T., Oda A., Yamamoto K., Kaneko M., Kikuyama S., Nishikawa A., Takahashi A., Kawauchi H., Tsutsui K., Fujimoto M. Molecular cloning and functional characterization of a prolactin-releasing peptide homolog from Xenopus laevis. Peptides. 2006;27:3347–3351. doi: 10.1016/j.peptides.2006.08.003. PubMed DOI

Tachibana T., Moriyama S., Takahashi A., Tsukada A., Oda A., Takeuchi S., Sakamoto T. Isolation and characterisation of prolactin-releasing peptide in chicks and its effect on prolactin release and feeding behaviour. J. Neuroendocrinol. 2011;23:74–81. doi: 10.1111/j.1365-2826.2010.02078.x. PubMed DOI

Lagerstrom M.C., Fredriksson R., Bjarnadottir T.K., Schioth H.B. The ancestry of the prolactin-releasing hormone precursor. Ann. N. Y. Acad. Sci. 2005;1040:368–370. doi: 10.1196/annals.1327.064. PubMed DOI

Matsumoto H., Noguchi J., Horikoshi Y., Kawamata Y., Kitada C., Hinuma S., Onda H., Nishimura O., Fujino M. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem. Biophys. Res. Commun. 1999;259:321–324. doi: 10.1006/bbrc.1999.0789. PubMed DOI

Lawrence C.B., Ellacott K.L., Luckman S.M. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology. 2002;143:360–367. doi: 10.1210/endo.143.2.8609. PubMed DOI

Samson W.K., Resch Z.T., Murphy T.C., Chang J.K. Gender-biased activity of the novel prolactin releasing peptides: Comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine. 1998;9:289–291. doi: 10.1385/ENDO:9:3:289. PubMed DOI

Lawrence C.B., Celsi F., Brennand J., Luckman S.M. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat. Neurosci. 2000;3:645–646. doi: 10.1038/76597. PubMed DOI

Seal L.J., Small C.J., Dhillo W.S., Stanley S.A., Abbott C.R., Ghatei M.A., Bloom S.R. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology. 2001;142:4236–4243. doi: 10.1210/endo.142.10.8419. PubMed DOI

Takayanagi Y., Matsumoto H., Nakata M., Mera T., Fukusumi S., Hinuma S., Ueta Y., Yada T., Leng G., Onaka T. Endogenous prolactin-releasing peptide regulates food intake in rodents. J. Clin. Investig. 2008;118:4014–4024. doi: 10.1172/JCI34682. PubMed DOI PMC

Onaka T., Takayanagi Y., Leng G. Metabolic and stress-related roles of prolactin-releasing peptide. Trends Endocrinol. Metab. 2010;21:287–293. doi: 10.1016/j.tem.2010.01.005. PubMed DOI

Maruyama M., Matsumoto H., Fujiwara K., Noguchi J., Kitada C., Fujino M., Inoue K. Prolactin-releasing peptide as a novel stress mediator in the central nervous system. Endocrinology. 2001;142:2032–2038. doi: 10.1210/endo.142.5.8118. PubMed DOI

Zhang S.Q., Inoue S., Kimura M. Sleep-promoting activity of prolactin-releasing peptide (PrRP) in the rat. Neuroreport. 2001;12:3173–3176. doi: 10.1097/00001756-200110290-00006. PubMed DOI

Zhang S.Q., Kimura M., Inoue S. Effects of prolactin-releasing peptide (PrRP) on sleep regulation in rats. Psychiatry Clin. Neurosci. 2000;54:262–264. doi: 10.1046/j.1440-1819.2000.00670.x. PubMed DOI

Samson W.K., Resch Z.T., Murphy T.C. A novel action of the newly described prolactin-releasing peptides: Cardiovascular regulation. Brain Res. 2000;858:19–25. doi: 10.1016/S0006-8993(99)02451-8. PubMed DOI

Mikulaskova B., Maletinska L., Zicha J., Kunes J. The role of food intake regulating peptides in cardiovascular regulation. Mol. Cell. Endocrinol. 2016;436:78–92. doi: 10.1016/j.mce.2016.07.021. PubMed DOI

Yamada T., Mochiduki A., Sugimoto Y., Suzuki Y., Itoi K., Inoue K. Prolactin-releasing peptide regulates the cardiovascular system via corticotrophin-releasing hormone. J. Neuroendocrinol. 2009;21:586–593. doi: 10.1111/j.1365-2826.2009.01875.x. PubMed DOI

Holubova M., Hruba L., Popelova A., Bencze M., Prazienkova V., Gengler S., Kratochvilova H., Haluzik M., Zelezna B., Kunes J., et al. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of beta-amyloid pathology. Neuropharmacology. 2019;144:377–387. doi: 10.1016/j.neuropharm.2018.11.002. PubMed DOI

Popelova A., Prazienkova V., Neprasova B., Kasperova B.J., Hruba L., Holubova M., Zemenova J., Blum D., Zelezna B., Galas M.C., et al. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy. J. Alzheimers Dis. 2018;62:1725–1736. doi: 10.3233/JAD-171041. PubMed DOI

Spolcova A., Mikulaskova B., Holubova M., Nagelova V., Pirnik Z., Zemenova J., Haluzik M., Zelezna B., Galas M.C., Maletinska L. Anorexigenic lipopeptides ameliorate central insulin signaling and attenuate tau phosphorylation in hippocampi of mice with monosodium glutamate-induced obesity. J. Alzheimers Dis. 2015;45:823–835. doi: 10.3233/JAD-143150. PubMed DOI

Marchese A., Heiber M., Nguyen T., Heng H.H., Saldivia V.R., Cheng R., Murphy P.M., Tsui L.C., Shi X., Gregor P., et al. Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics. 1995;29:335–344. doi: 10.1006/geno.1995.9996. PubMed DOI

Lagerstrom M.C., Fredriksson R., Bjarnadottir T.K., Fridmanis D., Holmquist T., Andersson J., Yan Y.L., Raudsepp T., Zoorob R., Kukkonen J.P., et al. Origin of the prolactin-releasing hormone (PRLH) receptors: Evidence of coevolution between PRLH and a redundant neuropeptide Y receptor during vertebrate evolution. Genomics. 2005;85:688–703. doi: 10.1016/j.ygeno.2005.02.007. PubMed DOI

Lin S.H. Results and Problems in Cell Differentiation. Volume 46. Springer; Berlin/Heidelberg, Germany: 2008. Prolactin-releasing peptide; pp. 57–88. PubMed DOI

Lin S.H., Arai A.C., Wang Z., Nothacker H.P., Civelli O. The carboxyl terminus of the prolactin-releasing peptide receptor interacts with PDZ domain proteins involved in alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor clustering. Mol. Pharmacol. 2001;60:916–923. doi: 10.1124/mol.60.5.916. PubMed DOI

Roland B.L., Sutton S.W., Wilson S.J., Luo L., Pyati J., Huvar R., Erlander M.G., Lovenberg T.W. Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology. 1999;140:5736–5745. doi: 10.1210/endo.140.12.7211. PubMed DOI

Engstrom M., Brandt A., Wurster S., Savola J.M., Panula P. Prolactin releasing peptide has high affinity and efficacy at neuropeptide FF2 receptors. J. Pharmacol. Exp. Ther. 2003;305:825–832. doi: 10.1124/jpet.102.047118. PubMed DOI

Elshourbagy N.A., Ames R.S., Fitzgerald L.R., Foley J.J., Chambers J.K., Szekeres P.G., Evans N.A., Schmidt D.B., Buckley P.T., Dytko G.M., et al. Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J. Biol. Chem. 2000;275:25965–25971. doi: 10.1074/jbc.M004515200. PubMed DOI

Bonini J.A., Jones K.A., Adham N., Forray C., Artymyshyn R., Durkin M.M., Smith K.E., Tamm J.A., Boteju L.W., Lakhlani P.P., et al. Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J. Biol. Chem. 2000;275:39324–39331. doi: 10.1074/jbc.M004385200. PubMed DOI

Fujii R., Fukusumi S., Hosoya M., Kawamata Y., Habata Y., Hinuma S., Sekiguchi M., Kitada C., Kurokawa T., Nishimura O., et al. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul. Pept. 1999;83:1–10. doi: 10.1016/S0167-0115(99)00028-2. PubMed DOI

Morales T., Hinuma S., Sawchenko P.E. Prolactin-releasing peptide is expressed in afferents to the endocrine hypothalamus, but not in neurosecretory neurones. J. Neuroendocrinol. 2000;12:131–140. doi: 10.1046/j.1365-2826.2000.00428.x. PubMed DOI

Matsumoto H., Murakami Y., Horikoshi Y., Noguchi J., Habata Y., Kitada C., Hinuma S., Onda H., Fujino M. Distribution and characterization of immunoreactive prolactin-releasing peptide (PrRP) in rat tissue and plasma. Biochem. Biophys. Res. Commun. 1999;257:264–268. doi: 10.1006/bbrc.1999.0463. PubMed DOI

Maruyama M., Matsumoto H., Fujiwara K., Kitada C., Hinuma S., Onda H., Fujino M., Inoue K. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology. 1999;140:2326–2333. doi: 10.1210/endo.140.5.6685. PubMed DOI

Nieminen M.L., Brandt A., Pietila P., Panula P. Expression of mammalian RF-amide peptides neuropeptide FF (NPFF), prolactin-releasing peptide (PrRP) and the PrRP receptor in the peripheral tissues of the rat. Peptides. 2000;21:1695–1701. doi: 10.1016/S0196-9781(00)00319-3. PubMed DOI

Reis F.M., Vigano P., Arnaboldi E., Spritzer P.M., Petraglia F., Di Blasio A.M. Expression of prolactin-releasing peptide and its receptor in the human decidua. Mol. Hum. Reprod. 2002;8:356–362. doi: 10.1093/molehr/8.4.356. PubMed DOI

Sakamoto T., Amano M., Hyodo S., Moriyama S., Takahashi A., Kawauchi H., Ando M. Expression of prolactin-releasing peptide and prolactin in the euryhaline mudskippers (Periophthalmus modestus): Prolactin-releasing peptide as a primary regulator of prolactin. J. Mol. Endocrinol. 2005;34:825–834. doi: 10.1677/jme.1.01768. PubMed DOI

Ibata Y., Iijima N., Kataoka Y., Kakihara K., Tanaka M., Hosoya M., Hinuma S. Morphological survey of prolactin-releasing peptide and its receptor with special reference to their functional roles in the brain. Neurosci. Res. 2000;38:223–230. doi: 10.1016/S0168-0102(00)00182-6. PubMed DOI

Nieminen M.L., Nystedt J., Panula P. Expression of neuropeptide FF, prolactin-releasing peptide, and the receptor UHR1/GPR10 genes during embryogenesis in the rat. Dev. Dyn. 2003;226:561–569. doi: 10.1002/dvdy.10261. PubMed DOI

Takahashi K., Totsune K., Murakami O., Sone M., Noshiro T., Hayashi Y., Sasano H., Shibahara S. Expression of prolactin-releasing peptide and its receptor in the human adrenal glands and tumor tissues of adrenocortical tumors, pheochromocytomas and neuroblastomas. Peptides. 2002;23:1135–1140. doi: 10.1016/S0196-9781(02)00046-3. PubMed DOI

Kimura A., Ohmichi M., Tasaka K., Kanda Y., Ikegami H., Hayakawa J., Hisamoto K., Morishige K., Hinuma S., Kurachi H., et al. Prolactin-releasing peptide activation of the prolactin promoter is differentially mediated by extracellular signal-regulated protein kinase and c-Jun N-terminal protein kinase. J. Biol. Chem. 2000;275:3667–3674. doi: 10.1074/jbc.275.5.3667. PubMed DOI

Langmead C.J., Szekeres P.G., Chambers J.K., Ratcliffe S.J., Jones D.N., Hirst W.D., Price G.W., Herdon H.J. Characterization of the binding of [(125)I]-human prolactin releasing peptide (PrRP) to GPR10, a novel G protein coupled receptor. Br. J. Pharmacol. 2000;131:683–688. doi: 10.1038/sj.bjp.0703617. PubMed DOI PMC

Duval D.L., Gutierrez-Hartmann A. PRL-releasing peptide stimulation of PRL gene transcription--enter AKT. Endocrinology. 2002;143:11–12. doi: 10.1210/endo.143.1.8647. PubMed DOI

Hayakawa J., Ohmichi M., Tasaka K., Kanda Y., Adachi K., Nishio Y., Hisamoto K., Mabuchi S., Hinuma S., Murata Y. Regulation of the PRL promoter by Akt through cAMP response element binding protein. Endocrinology. 2002;143:13–22. doi: 10.1210/endo.143.1.8586. PubMed DOI

Nanmoku T., Takekoshi K., Fukuda T., Ishii K., Isobe K., Kawakami Y. Stimulation of catecholamine biosynthesis via the PKC pathway by prolactin-releasing peptide in PC12 rat pheochromocytoma cells. J. Endocrinol. 2005;186:233–239. doi: 10.1677/joe.1.05919. PubMed DOI

Nanmoku T., Takekoshi K., Isobe K., Kawakami Y., Nakai T., Okuda Y. Prolactin-releasing peptide stimulates catecholamine release but not proliferation in rat pheochromocytoma PC12 cells. Neurosci. Lett. 2003;350:33–36. doi: 10.1016/S0304-3940(03)00836-X. PubMed DOI

Samson W.K., Taylor M.M. Prolactin releasing peptide (PrRP): An endogenous regulator of cell growth. Peptides. 2006;27:1099–1103. doi: 10.1016/j.peptides.2006.01.008. PubMed DOI

Tachibana T., Sakamoto T. Functions of two distinct “prolactin-releasing peptides” evolved from a common ancestral gene. Front. Endocrinol. 2014;5:170. doi: 10.3389/fendo.2014.00170. PubMed DOI PMC

Varghese B.V., Koohestani F., McWilliams M., Colvin A., Gunewardena S., Kinsey W.H., Nowak R.A., Nothnick W.B., Chennathukuzhi V.M. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Proc. Natl. Acad. Sci. USA. 2013;110:2187–2192. doi: 10.1073/pnas.1215759110. PubMed DOI PMC

Maixnerova J., Spolcova A., Pychova M., Blechova M., Elbert T., Rezacova M., Zelezna B., Maletinska L. Characterization of prolactin-releasing peptide: Binding, signaling and hormone secretion in rodent pituitary cell lines endogenously expressing its receptor. Peptides. 2011;32:811–817. doi: 10.1016/j.peptides.2010.12.011. PubMed DOI

Maletinska L., Nagelova V., Ticha A., Zemenova J., Pirnik Z., Holubova M., Spolcova A., Mikulaskova B., Blechova M., Sykora D., et al. Novel lipidized analogs of prolactin-releasing peptide have prolonged half-lives and exert anti-obesity effects after peripheral administration. Int. J. Obes. (Lond.) 2015;39:986–993. doi: 10.1038/ijo.2015.28. PubMed DOI

Boyle R.G., Downham R., Ganguly T., Humphries J., Smith J., Travers S. Structure-activity studies on prolactin-releasing peptide (PrRP). Analogues of PrRP-(19-31)-peptide. J. Pept. Sci. Off. Publ. Eur. Pept. Soc. 2005;11:161–165. doi: 10.1002/psc.612. PubMed DOI

Deluca S.H., Rathmann D., Beck-Sickinger A.G., Meiler J. The activity of prolactin releasing peptide correlates with its helicity. Biopolymers. 2013;99:314–325. doi: 10.1002/bip.22162. PubMed DOI PMC

Maletinska L., Spolcova A., Maixnerova J., Blechova M., Zelezna B. Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide. Peptides. 2011;32:1887–1892. doi: 10.1016/j.peptides.2011.08.011. PubMed DOI

Quillet R., Ayachi S., Bihel F., Elhabazi K., Ilien B., Simonin F. RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions. Pharmacol. Ther. 2016;160:84–132. doi: 10.1016/j.pharmthera.2016.02.005. PubMed DOI

D’Ursi A.M., Albrizio S., Di Fenza A., Crescenzi O., Carotenuto A., Picone D., Novellino E., Rovero P. Structural studies on Hgr3 orphan receptor ligand prolactin-releasing peptide. J. Med. Chem. 2002;45:5483–5491. doi: 10.1021/jm020975p. PubMed DOI

Brasnjevic I., Steinbusch H.W., Schmitz C., Martinez-Martinez P., European NanoBioPharmaceutics Research I. Delivery of peptide and protein drugs over the blood-brain barrier. Prog. Neurobiol. 2009;87:212–251. doi: 10.1016/j.pneurobio.2008.12.002. PubMed DOI

Knudsen L.B., Nielsen P.F., Huusfeldt P.O., Johansen N.L., Madsen K., Pedersen F.Z., Thogersen H., Wilken M., Agerso H. Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration. J. Med. Chem. 2000;43:1664–1669. doi: 10.1021/jm9909645. PubMed DOI

Gault V.A., Kerr B.D., Harriott P., Flatt P.R. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity. Clin. Sci. (Lond.) 2011;121:107–117. doi: 10.1042/CS20110006. PubMed DOI

Kunes J., Prazienkova V., Popelova A., Mikulaskova B., Zemenova J., Maletinska L. Prolactin-releasing peptide: A new tool for obesity treatment. J. Endocrinol. 2016;230:R51–R58. doi: 10.1530/JOE-16-0046. PubMed DOI

Prazienkova V., Ticha A., Blechova M., Spolcova A., Zelezna B., Maletinska L. Pharmacological characterization of lipidized analogs of prolactin-releasing peptide with a modified C- terminal aromatic ring. J. Physiol. Pharmacol. Off. J. Pol. Physiol. Soc. 2016;67:121–128. PubMed

Prazienkova V., Holubova M., Pelantova H., Buganova M., Pirnik Z., Mikulaskova B., Popelova A., Blechova M., Haluzik M., Zelezna B., et al. Impact of novel palmitoylated prolactin-releasing peptide analogs on metabolic changes in mice with diet-induced obesity. PLoS ONE. 2017;12:e0183449. doi: 10.1371/journal.pone.0183449. PubMed DOI PMC

Pflimlin E., Lear S., Lee C., Yu S., Zou H., To A., Joseph S., Nguyen-Tran V., Tremblay M.S., Shen W. Design of a Long-Acting and Selective MEG-Fatty Acid Stapled Prolactin-Releasing Peptide Analog. ACS Med. Chem. Lett. 2019;10:1166–1172. doi: 10.1021/acsmedchemlett.9b00182. PubMed DOI PMC

Lawrence C.B., Liu Y.L., Stock M.J., Luckman S.M. Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004;286:R101–R107. doi: 10.1152/ajpregu.00402.2003. PubMed DOI

Arora S., Anubhuti Role of neuropeptides in appetite regulation and obesity—A review. Neuropeptides. 2006;40:375–401. doi: 10.1016/j.npep.2006.07.001. PubMed DOI

Sohn J.W. Network of hypothalamic neurons that control appetite. BMB Rep. 2015;48:229–233. doi: 10.5483/BMBRep.2015.48.4.272. PubMed DOI PMC

Schwartz M.W., Woods S.C., Porte D., Jr., Seeley R.J., Baskin D.G. Central nervous system control of food intake. Nature. 2000;404:661–671. doi: 10.1038/35007534. PubMed DOI

Ellacott K.L., Lawrence C.B., Rothwell N.J., Luckman S.M. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology. 2002;143:368–374. doi: 10.1210/endo.143.2.8608. PubMed DOI

Vergoni A.V., Watanobe H., Guidetti G., Savino G., Bertolini A., Schioth H.B. Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats. Brain Res. 2002;955:207–213. doi: 10.1016/S0006-8993(02)03462-5. PubMed DOI

Ellacott K.L., Lawrence C.B., Pritchard L.E., Luckman S.M. Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003;285:R1005–R1010. doi: 10.1152/ajpregu.00237.2003. PubMed DOI

Gu W., Geddes B.J., Zhang C., Foley K.P., Stricker-Krongrad A. The prolactin-releasing peptide receptor (GPR10) regulates body weight homeostasis in mice. J. Mol. Neurosci. 2004;22:93–103. doi: 10.1385/JMN:22:1-2:93. PubMed DOI

Bjursell M., Lenneras M., Goransson M., Elmgren A., Bohlooly Y.M. GPR10 deficiency in mice results in altered energy expenditure and obesity. Biochem. Biophys. Res. Commun. 2007;363:633–638. doi: 10.1016/j.bbrc.2007.09.016. PubMed DOI

Bechtold D.A., Luckman S.M. Prolactin-releasing Peptide mediates cholecystokinin-induced satiety in mice. Endocrinology. 2006;147:4723–4729. doi: 10.1210/en.2006-0753. PubMed DOI

Mochiduki A., Takeda T., Kaga S., Inoue K. Stress response of prolactin-releasing peptide knockout mice as to glucocorticoid secretion. J. Neuroendocrinol. 2010;22:576–584. doi: 10.1111/j.1365-2826.2010.01993.x. PubMed DOI

Matsumoto H., Maruyama M., Noguchi J., Horikoshi Y., Fujiwara K., Kitada C., Hinuma S., Onda H., Nishimura O., Inoue K., et al. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci. Lett. 2000;285:234–238. doi: 10.1016/S0304-3940(00)01077-6. PubMed DOI

Mera T., Fujihara H., Kawasaki M., Hashimoto H., Saito T., Shibata M., Saito J., Oka T., Tsuji S., Onaka T., et al. Prolactin-releasing peptide is a potent mediator of stress responses in the brain through the hypothalamic paraventricular nucleus. Neuroscience. 2006;141:1069–1086. doi: 10.1016/j.neuroscience.2006.04.023. PubMed DOI

Seal L.J., Small C.J., Dhillo W.S., Kennedy A.R., Ghatei M.A., Bloom S.R. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology. 2002;76:70–78. doi: 10.1159/000064427. PubMed DOI

Kelly S.P., Peter R.E. Prolactin-releasing peptide, food intake, and hydromineral balance in goldfish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2006;291:R1474–R1481. doi: 10.1152/ajpregu.00129.2006. PubMed DOI

Tachibana T., Saito S., Tomonaga S., Takagi T., Saito E.S., Nakanishi T., Koutoku T., Tsukada A., Ohkubo T., Boswell T., et al. Effect of central administration of prolactin-releasing peptide on feeding in chicks. Physiol. Behav. 2004;80:713–719. doi: 10.1016/j.physbeh.2003.12.005. PubMed DOI

Tachibana T., Tsukada A., Fujimoto M., Takahashi H., Ohkubo T., Boswell T., Furuse M. Comparison of mammalian prolactin-releasing peptide and Carassius RFamide for feeding behavior and prolactin secretion in chicks. Gen. Comp. Endocrinol. 2005;144:264–269. doi: 10.1016/j.ygcen.2005.06.012. PubMed DOI

Pirnik Z., Zelezna B., Kiss A., Maletinska L. Peripheral administration of palmitoylated prolactin-releasing peptide induces Fos expression in hypothalamic neurons involved in energy homeostasis in NMRI male mice. Brain Res. 2015;1625:151–158. doi: 10.1016/j.brainres.2015.08.042. PubMed DOI

Mikulaskova B., Zemenova J., Pirnik Z., Prazienkova V., Bednarova L., Zelezna B., Maletinska L., Kunes J. Effect of palmitoylated prolactin-releasing peptide on food intake and neural activation after different routes of peripheral administration in rats. Peptides. 2016;75:109–117. doi: 10.1016/j.peptides.2015.11.005. PubMed DOI

Pirnik Z., Kolesarova M., Zelezna B., Maletinska L. Repeated peripheral administration of lipidized prolactin-releasing peptide analog induces c-fos and FosB expression in neurons of dorsomedial hypothalamic nucleus in male C57 mice. Neurochem. Int. 2018;116:77–84. doi: 10.1016/j.neuint.2018.03.013. PubMed DOI

Holubova M., Zemenova J., Mikulaskova B., Panajotova V., Stohr J., Haluzik M., Kunes J., Zelezna B., Maletinska L. Palmitoylated PrRP analog decreases body weight in rats with DIO but not in ZDF rats. J. Endocrinol. 2016 doi: 10.1530/JOE-15-0519. PubMed DOI

Mikulaskova B., Holubova M., Prazienkova V., Zemenova J., Hruba L., Haluzik M., Zelezna B., Kunes J., Maletinska L. Lipidized prolactin-releasing peptide improved glucose tolerance in metabolic syndrome: Koletsky and spontaneously hypertensive rat study. Nutr. Diabetes. 2018;8:5. doi: 10.1038/s41387-017-0015-8. PubMed DOI PMC

Cermakova M., Pelantova H., Neprasova B., Sediva B., Maletinska L., Kunes J., Tomasova P., Zelezna B., Kuzma M. Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats. J. Proteome Res. 2019;18:1735–1750. doi: 10.1021/acs.jproteome.8b00964. PubMed DOI

Hassing L.B., Dahl A.K., Thorvaldsson V., Berg S., Gatz M., Pedersen N.L., Johansson B. Overweight in midlife and risk of dementia: A 40-year follow-up study. Int. J. Obes. (Lond.) 2009;33:893–898. doi: 10.1038/ijo.2009.104. PubMed DOI PMC

Kadohara K., Sato I., Kawakami K. Diabetes mellitus and risk of early-onset Alzheimer’s disease: A population-based case-control study. Eur. J. Neurol. 2017;24:944–949. doi: 10.1111/ene.13312. PubMed DOI

Serrano-Pozo A., Frosch M.P., Masliah E., Hyman B.T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2011;1:a006189. doi: 10.1101/cshperspect.a006189. PubMed DOI PMC

Maletinska L., Popelova A., Zelezna B., Bencze M., Kunes J. The impact of anorexigenic peptides in experimental models of Alzheimer’s disease pathology. J. Endocrinol. 2019;240:R47–R72. doi: 10.1530/JOE-18-0532. PubMed DOI

Prazienkova V., Schirmer C., Holubova M., Zelezna B., Kunes J., Galas M.C., Maletinska L. Lipidized Prolactin-Releasing Peptide Agonist Attenuates Hypothermia-Induced Tau Hyperphosphorylation in Neurons. J. Alzheimers Dis. 2019;67:1187–1200. doi: 10.3233/JAD-180837. PubMed DOI

Hirata A.E., Andrade I.S., Vaskevicius P., Dolnikoff M.S. Monosodium glutamate (MSG)-obese rats develop glucose intolerance and insulin resistance to peripheral glucose uptake. Braz. J. Med Biol. Res. Rev. Bras. Pesqui. Med. Biol. Soc. Bras. Biofisica. 1997;30:671–674. doi: 10.1590/S0100-879X1997000500016. PubMed DOI

Matyskova R., Maletinska L., Maixnerova J., Pirnik Z., Kiss A., Zelezna B. Comparison of the obesity phenotypes related to monosodium glutamate effect on arcuate nucleus and/or the high fat diet feeding in C57BL/6 and NMRI mice. Physiol. Res. 2008;57:727–734. PubMed

Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: A comparison of strategies. Biomol. Eng. 2001;17:157–165. doi: 10.1016/S1389-0344(01)00067-3. PubMed DOI

Maniscalco J.W., Rinaman L. Interoceptive modulation of neuroendocrine, emotional, and hypophagic responses to stress. Physiol. Behav. 2017;176:195–206. doi: 10.1016/j.physbeh.2017.01.027. PubMed DOI PMC

Morales T., Sawchenko P.E. Brainstem prolactin-releasing peptide neurons are sensitive to stress and lactation. Neuroscience. 2003;121:771–778. doi: 10.1016/S0306-4522(03)00522-0. PubMed DOI

Card J.P., Johnson A.L., Llewellyn-Smith I.J., Zheng H., Anand R., Brierley D.I., Trapp S., Rinaman L. GLP-1 neurons form a local synaptic circuit within the rodent nucleus of the solitary tract. J. Comp. Neurol. 2018;526:2149–2164. doi: 10.1002/cne.24482. PubMed DOI PMC

Zhu L.L., Onaka T. Facilitative role of prolactin-releasing peptide neurons in oxytocin cell activation after conditioned-fear stimuli. Neuroscience. 2003;118:1045–1053. doi: 10.1016/S0306-4522(03)00059-9. PubMed DOI

Quillet R., Simonin F. The neuropeptide FF: A signal for M1 to M2 type switching in macrophages from the adipose tissue. Med. Sci. (Paris) 2018;34:27–29. doi: 10.1051/medsci/20183401008. PubMed DOI

Ma L., MacTavish D., Simonin F., Bourguignon J.J., Watanabe T., Jhamandas J.H. Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor. Eur. J. Neurosci. 2009;30:1585–1593. doi: 10.1111/j.1460-9568.2009.06956.x. PubMed DOI

Lin S.H., Leslie F.M., Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: Evidence for a role of PrRP as a regulator of stress and nociception. Brain Res. 2002;952:15–30. doi: 10.1016/S0006-8993(02)03183-9. PubMed DOI

Laurent P., Becker J.A., Valverde O., Ledent C., de Kerchove d’Exaerde A., Schiffmann S.N., Maldonado R., Vassart G., Parmentier M. The prolactin-releasing peptide antagonizes the opioid system through its receptor GPR10. Nat. Neurosci. 2005;8:1735–1741. doi: 10.1038/nn1585. PubMed DOI

Fujiwara K., Matsumoto H., Yada T., Inoue K. Identification of the prolactin-releasing peptide-producing cell in the rat adrenal gland. Regul. Pept. 2005;126:97–102. doi: 10.1016/j.regpep.2004.08.039. PubMed DOI

Feng Y., Zhao H., An X.F., Ma S.L., Chen B.Y. Expression of brain prolactin releasing peptide (PrRP) changes in the estrous cycle of female rats. Neurosci. Lett. 2007;419:38–42. doi: 10.1016/j.neulet.2007.03.069. PubMed DOI

Maruyama M., Matsumoto H., Fujiwara K., Noguchi J., Kitada C., Hinuma S., Onda H., Nishimura O., Fujino M., Higuchi T., et al. Central administration of prolactin-releasing peptide stimulates oxytocin release in rats. Neurosci. Lett. 1999;276:193–196. doi: 10.1016/S0304-3940(99)00831-9. PubMed DOI

Deficiency of GPR10 and NPFFR2 receptors leads to sex-specific prediabetic syndrome and late-onset obesity in mice

Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides

An analogue of the Prolactin Releasing Peptide reduces obesity and promotes adult neurogenesis

Lipidization as a tool toward peptide therapeutics

Cholecystokinin system is involved in the anorexigenic effect of peripherally applied palmitoylated prolactin-releasing peptide in fasted mice

Cellular Signaling and Anti-Apoptotic Effects of Prolactin-Releasing Peptide and Its Analog on SH-SY5Y Cells